Frequency of breast cancer attributable to BRCA1 in a population-based series of American women

JAMA

Volumn 279, Issue 12, 1998, Pages 915-921

  Newman, Beth ^a   Mu, Hua ^b   Butler, Lesley M ^a,b   Millikan, Robert C ^a   Moorman, Patricia G ^a,c   King, Mary Claire ^b  

^a University of North Carolina at Chapel Hill   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c YALE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BREAST CARCINOGENESIS; BREAST CARCINOMA; CANCER INCIDENCE; FAMILY HISTORY; FEMALE; GENE MUTATION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RACE DIFFERENCE; UNITED STATES;

EID: 0032565070     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.279.12.915     Document Type: Article

References (54)

1. National Advisory Council for Human Genome Research. Statement of use of DNA testing for presymptomatic identification of cancer risk. JAMA. 1994;271:785.
2. American Society of Human Genetics Ad Hoc Committee on Genetic Testing for Breast and Ovarian Cancer. Statement of genetic testing for breast and ovarian cancer predisposition. Am J Hum Genet. 1994;55:2-4.
3. American Society of Clinical Oncology. Genetic testing for cancer susceptibility. J Clin Oncol. 1996; 14:1730-1736.
4. Hall J, Lee M, Newman B, et al. Linkage of early onset familial breast cancer to chromosome 17q21. Science. 1990;250:1684-1689.
5. Narod SA, Feunteun J, Lynch HT, et al. Familial breast-ovarian cancer locus on chromosome 17q12-q23. Lancet. 1991;338:82-83.
6. Miki Y, Swenson J, Shattuck-Eidens D, et al. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science. 1994;266:66-71.
7. Breast Cancer Information Core. Breast cancer information web site. Available at: http://www .nhgri.nih.gov/Intramural_research/Lab_transfer /Bic/index.html. Accessed August 1997.
8. Newman B, Moorman PG, Millikan R, et al. The Carolina Breast Cancer Study: integrating population-based epidemiology and molecular biology. Breast Cancer Res Treat. 1995;35:51-60.
9. Aldrich TE, Vann D, Moorman PG, Newman B. Rapid reporting of cancer incidence in a population-based study of breast cancer: one constructive use of a central cancer registry. Breast Cancer Res Treat. 1995;35:61-64.
10. Weinberg CR, Wacholder S. The design and analysis of case-control studies with biased sampling. Biometrics. 1990;46:963-975.
11. Weinberg CR, Sandler DP. Randomized recruitment in case-control studies. Am J Epidemiol. 1991;134:421-432.
12. Friedman LS, Ostermeyer EA, Szabo CI, et al. Confirmation of BRCA1 by analysis of germline mutations linked to breast and ovarian cancer in ten families. Nat Genet. 1994;8:399-404.
13. Friedman LS, Szabo CI, Ostermeyer EA, et al. Novel inherited mutations and variable expressivity of BRCA1 alleles, including the founder mutation 185delAG in Ashkenazi Jewish families. Am J Hum Genet. 1995;57:1284-1297.
14. SAS/STAT Software. Changes and Enhancements Through Release 6.11. Cary, NC: SAS Institute Inc; 1996.
15. Research Triangle Institute. SUDAAN Software for the Statistical Analyses of Correlated Data. Research Triangle Park, NC: Research Triangle Institute; 1996.
16. SAS/STAT Software. The GENMOD Procedure: SAS Technical Report p-243. Cary, NC: SAS Institute Inc; 1993.
17. Neuhausen SL, Mazoyer S, Friedman L, et al. Haplotype and phenotype analysis of six recurrent BRCA1 mutations in 61 families: results of an international study. Am J Hum Genet. 1996;58: 271-280.
18. Peelan T, Van Vliet M, Petrij-Bosch A, et al. Specific mutation distribution in BRCA1 with strong founder effects among Dutch and Belgian hereditary breast and ovarian cancer families. Am J Hum Genet. 1997;60:1041-1049.
19. Arena J, Smith S, Plewinska M, et al. BRCA1 mutations in African-American women. Am J Hum Genet. 1996;59:34.
20. Gao Q, Neuhausen S, Cummings S, et al. Recurrent germline BRCA1 mutations in extended African-American families with early-onset breast cancer. Am J Hum Genet. 1997;60:1233-1235.
21. Newman B, Austin MA, Lee M, King M-C. Inheritance of human breast cancer evidence for autosomal dominant transmission in high-risk families. Proc Natl Acad Sci U S A. 1988;85:3044-3048.
22. Claus EB, Risch N, Thompson WD. Genetic analysis of breast cancer in the Cancer and Steroid Hormone Study. Am J Hum Genet. 1991;48:232-242.
23. Whittemore AS, Gong G, Itnyre J. Prevalence and contribution of BRCA1 mutations in breast cancer and ovarian cancer: results from three US population-based case-control studies of ovarian cancer. Am J Hum Genet. 1997;60:496-504.
24. Ford D, Easton DF, Peto J. Estimates of the gene frequency of BRCA1 and its contribution to breast and ovarian cancer incidence. Am J Hum Genet. 1995;57:1457-1462.
25. Schubert E, Lee M, Mefford H, et al. BRCA2 in American families with four or more cases of breast or ovarian cancer: recurrent and novel mutations, variable expression, penetrance, and characteristics of families not attributable to BRCA1 or BRCA2. Am J Hum Genet. 1997;60:1031-1040.
26. Rebbeck TR, Couch FJ, Kant J, et al. Genetic heterogeneity in hereditary breast cancer: role of BRCA1 and BRCA2. Am J Hum Genet. 1996;59: 547-553.
27. Narod S, Ford D, Devilee P, et al. Genetic heterogeneity of breast-ovarian cancer revisited. Am J Hum Genet. 1995;57:957-958.
28. Easton DF, Bishop DT, Ford D, et al. Genetic linkage analysis in familial breast and ovarian cancer: results from 214 families. Am J Hum Genet. 1993;52:678-701.
29. FitzGerald MG, MacDonald DJ, Krainer M, et al. Germ-line BACA1 mutations in Jewish and non-Jewish women with early-onset breast cancer. N Engl J Med. 1996;334:143-149.
30. Krainer M, Silva-Arrieta S, FitzGerald MG, et al. Differential contributions of BRCA1 and BRCA2 to early-onset breast cancer. N Engl J Med. 1997; 336:1416-1421.
31. Couch FJ, DeShano ML, Blackwood A, et al. BRCA1 mutations in women attending clinics that evaluate the risk of breast cancer. N Engl J Med. 1997;336:1409-1415.
32. Shattuck-Eidens D, Oliphant A, McClure M, et al. BRCA1 sequence analysis in women at high risk for susceptibility mutations: risk factor analysis and implications for genetic testing. JAMA. 1997;278: 1242-1250.
33. Langston AA, Malone KE, Thompson JD, et al. BRCA1 mutations in a population-based sample of young women with breast cancer. N Engl J Med. 1996;334:137-142.
34. Durocher F, Shattuck-Eidens D, McClure M, et al. Comparison of BRCA1 polymorphisms, rare sequence variants and/or missense mutations in unaffected and breast/ovarian cancer populations. Hum Mol Genet. 1996;5:835-842.
35. Sachs AB. Messenger RNA degradation in eukaryotes. Cell. 1993;74:413-421.
36. Struewing JP, Hartge P, Wacholder S, et al. The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews. N Engl J Med. 1997;336:1401-1408.
37. Langston AA, Stanford JL, Wicklund KG, et al. Germ-line BRCA1 mutations in selected men with prostate cancer. Am J Hum Genet. 1996;58:881-885.
38. Ford D, Easton DF, Bishop DT, et al. Risks of cancer in BRCA1-mutation carriers. Lancet. 1994; 343:692-695.
39. Margaritte P, Bonaiti-Pellie C, King M-C, Clerget-Darpoux F. Linkage of familial breast cancer to chromosome 17q21 may not be restricted to early-onset disease. Am J Hum Genet, 1992;50: 1231-1234.
40. Fuget N, Torchard D, Serova-Sinilnikova OM, et al. A 1-kb Alu-mediated germline deletion removing BACA1 exon 17. Cancer Res. 1997;57:828-831.
41. Petrij-Bosch A, Peelen T, van Vliet M, et al. BRCA1 genomic deletions are major founder mutations in Dutch breast cancer patients. Nat Genet. 1997;17:341-345.
42. Serova O, Mazoyer S, Puget N, et al. Mutations in BRCA1 and BRCA2 in breast cancer families: are there more breast cancer susceptibility genes? Am J Hum Genet. 1997;60:486-495.
43. Kerlikowske K, Grady D, Rubin S, et al. Efficacy of screening mammography: a meta-analysis. JAMA. 1995;273:149-154.
44. Fletcher SW. Whither scientific deliberation in health policy recommendations? Alice in the Wonderland of breast-cancer screening. N Engl J Med. 1997;336:1180-1183.
45. Kerlikowske K, Grady D, Barclay J, et al. Effect of age, breast density, and family history on the sensitivity of first screening mammography. JAMA. 1996;276:33-38.
46. Hartmann L, Jenkins R, Schaid D, Yang P. Prophylactic mastectomy: preliminary retrospective cohort analysis [abstract]. Proc Am Assoc Cancer Res. 1997;38:168.
47. Ford LG, Johnson KA. Tamoxifen breast cancer prevention trial - an update. Prog Clin Biol Res. 1997;396:271-282.
48. Collins FS. BRCA1 - lots of mutations, lots of dilemmas. N Engl J Med. 1996;334:186-188.
49. Healy B. BACA genes - bookmaking, fortune-telling, and medical care. N Engl J Med. 1997;336: 1448-1449.
50. Rothenberg K, Fuller B, Rothstein M, et al. Genetic information and the workplace: legislative approaches and policy challenges. Science. 1997;275: 1755-1757.
51. Rothenberg KH. Genetic information and health insurance: state legislative approaches. J Law Med Ethics. 1995;23:312-319.
52. Hubbard R, Lewontin RC. Pitfalls of genetic testing. N Engl J Med. 1996;334:1192-1194.
53. Hubbard R, Wald E. Exploding the Gene Myth. Boston, Mass: Beacon Press; 1993.
54. Bradley MB, Green NM Jr, Jones DE, et al. Churches and Church Membership in the United States, 1990. Atlanta, Ga: Glenmary Research Center; 1992.